Jiaqiang Cai
Co-founder ,Chief Scientific Officer & Co-Chief Executive Officer Medilink Therapeutics
Seminars
Tuesday 9th March 2027
Unveiling Non-Internalizing ADC: Linker-Payload Technologies & Clinical Products
6:15 pm
- Highlighting current non-internalizing ADC linker-payload technologies and its challenges
- Demonstrating in vitro and in vivo mechanistic studies with TMALIN ADC technology
- Sharing clinical product examples from TMALIN linker-payload technology to achieve better efficacy, low toxicity and a bigger ADC target space
